PanCareSurPass Project HL7 FHIR Implementation Guide
1.0.0 - release 150

PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions

## : PCSP Conditions at risk - TTL Representation

Active as of 2026-01-16

Raw ttl | Download

    @prefix fhir: <http://hl7.org/fhir/> .
    @prefix owl: <http://www.w3.org/2002/07/owl#> .
    @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
    @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
    @prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

    # - resource -------------------------------------------------------------------

     a fhir:CodeSystem ;
      fhir:nodeRole fhir:treeRoot ;
      fhir:id [ fhir:v "cs-riskcondition-eu-pcsp"] ; #
      fhir:text [
    fhir:status [ fhir:v "generated" ] ;
    fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cs-riskcondition-eu-pcsp</b></p><a name=\"cs-riskcondition-eu-pcsp\"> </a><a name=\"hccs-riskcondition-eu-pcsp\"> </a><p>This case-sensitive code system <code>http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">1<a name=\"cs-riskcondition-eu-pcsp-1\"> </a></td><td>Subsequent thyroid cancer</td><td>Subsequent thyroid cancer</td></tr><tr><td style=\"white-space:nowrap\">2<a name=\"cs-riskcondition-eu-pcsp-2\"> </a></td><td>Subsequent breast cancer</td><td>Subsequent breast cancer</td></tr><tr><td style=\"white-space:nowrap\">3<a name=\"cs-riskcondition-eu-pcsp-3\"> </a></td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td></tr><tr><td style=\"white-space:nowrap\">4<a name=\"cs-riskcondition-eu-pcsp-4\"> </a></td><td>Impaired fertility Impaired spermatogenesis</td><td>Impaired fertility Impaired spermatogenesis</td></tr><tr><td style=\"white-space:nowrap\">5<a name=\"cs-riskcondition-eu-pcsp-5\"> </a></td><td>Testosterone deficiency</td><td>Testosterone deficiency</td></tr><tr><td style=\"white-space:nowrap\">6<a name=\"cs-riskcondition-eu-pcsp-6\"> </a></td><td>Physical sexual dysfunction</td><td>Physical sexual dysfunction</td></tr><tr><td style=\"white-space:nowrap\">7<a name=\"cs-riskcondition-eu-pcsp-7\"> </a></td><td>Premature ovarian insufficiency</td><td>Premature ovarian insufficiency</td></tr><tr><td style=\"white-space:nowrap\">8<a name=\"cs-riskcondition-eu-pcsp-8\"> </a></td><td>Ear problems</td><td>Ear problems</td></tr><tr><td style=\"white-space:nowrap\">9<a name=\"cs-riskcondition-eu-pcsp-9\"> </a></td><td>Impaired glucose metabolism and diabetes melitus</td><td>Impaired glucose metabolism and diabetes melitus</td></tr><tr><td style=\"white-space:nowrap\">10<a name=\"cs-riskcondition-eu-pcsp-10\"> </a></td><td>Dyslipidemia</td><td>Dyslipidemia</td></tr><tr><td style=\"white-space:nowrap\">11<a name=\"cs-riskcondition-eu-pcsp-11\"> </a></td><td>Overweight and obesity</td><td>Overweight and obesity</td></tr><tr><td style=\"white-space:nowrap\">12<a name=\"cs-riskcondition-eu-pcsp-12\"> </a></td><td>Hypertension</td><td>Hypertension</td></tr><tr><td style=\"white-space:nowrap\">13<a name=\"cs-riskcondition-eu-pcsp-13\"> </a></td><td>Reduced bone mineral density</td><td>Reduced bone mineral density</td></tr><tr><td style=\"white-space:nowrap\">14<a name=\"cs-riskcondition-eu-pcsp-14\"> </a></td><td>Osteonecrosis</td><td>Osteonecrosis</td></tr><tr><td style=\"white-space:nowrap\">15<a name=\"cs-riskcondition-eu-pcsp-15\"> </a></td><td>Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td><td>Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td></tr><tr><td style=\"white-space:nowrap\">16<a name=\"cs-riskcondition-eu-pcsp-16\"> </a></td><td>Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td><td>Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td></tr><tr><td style=\"white-space:nowrap\">17<a name=\"cs-riskcondition-eu-pcsp-17\"> </a></td><td>Central precocious puberty (CPP) For girls with age below 8 years</td><td>Central precocious puberty (CPP) For girls with age below 8 years</td></tr><tr><td style=\"white-space:nowrap\">18<a name=\"cs-riskcondition-eu-pcsp-18\"> </a></td><td>Central precocious puberty (CPP) For boys with age below 9 yearss</td><td>Central precocious puberty (CPP) For boys with age below 9 yearss</td></tr><tr><td style=\"white-space:nowrap\">19<a name=\"cs-riskcondition-eu-pcsp-19\"> </a></td><td>Thyroid function problems</td><td>Thyroid function problems</td></tr><tr><td style=\"white-space:nowrap\">20<a name=\"cs-riskcondition-eu-pcsp-20\"> </a></td><td>Cerebrovascular problem</td><td>Cerebrovascular problem</td></tr><tr><td style=\"white-space:nowrap\">21<a name=\"cs-riskcondition-eu-pcsp-21\"> </a></td><td>Neurocognitive problems</td><td>Neurocognitive problems</td></tr><tr><td style=\"white-space:nowrap\">22<a name=\"cs-riskcondition-eu-pcsp-22\"> </a></td><td>Peripheral neuropathy</td><td>Peripheral neuropathy</td></tr><tr><td style=\"white-space:nowrap\">23<a name=\"cs-riskcondition-eu-pcsp-23\"> </a></td><td>Cataract</td><td>Cataract</td></tr><tr><td style=\"white-space:nowrap\">24<a name=\"cs-riskcondition-eu-pcsp-24\"> </a></td><td>Eye problems</td><td>Eye problems</td></tr><tr><td style=\"white-space:nowrap\">25<a name=\"cs-riskcondition-eu-pcsp-25\"> </a></td><td>Craniofacial growth problems</td><td>Craniofacial growth problems</td></tr><tr><td style=\"white-space:nowrap\">26<a name=\"cs-riskcondition-eu-pcsp-26\"> </a></td><td>Spine scoliosis and kyphosis</td><td>Spine scoliosis and kyphosis</td></tr><tr><td style=\"white-space:nowrap\">27<a name=\"cs-riskcondition-eu-pcsp-27\"> </a></td><td>Lower urinary tract problems</td><td>Lower urinary tract problems</td></tr><tr><td style=\"white-space:nowrap\">28<a name=\"cs-riskcondition-eu-pcsp-28\"> </a></td><td>Obstetric problems</td><td>Obstetric problems</td></tr><tr><td style=\"white-space:nowrap\">29<a name=\"cs-riskcondition-eu-pcsp-29\"> </a></td><td>Dental and oral problems</td><td>Dental and oral problems</td></tr><tr><td style=\"white-space:nowrap\">30<a name=\"cs-riskcondition-eu-pcsp-30\"> </a></td><td>Gastro-intestinal problems</td><td>Gastro-intestinal problems</td></tr><tr><td style=\"white-space:nowrap\">31<a name=\"cs-riskcondition-eu-pcsp-31\"> </a></td><td>Arrhythmia</td><td>Arrhythmia</td></tr><tr><td style=\"white-space:nowrap\">32<a name=\"cs-riskcondition-eu-pcsp-32\"> </a></td><td>Pulmonary problems</td><td>Pulmonary problems</td></tr><tr><td style=\"white-space:nowrap\">33<a name=\"cs-riskcondition-eu-pcsp-33\"> </a></td><td>Renal problems (Glomerular dysfunction - Tubular dysfunction)</td><td>Renal problems (Glomerular dysfunction - Tubular dysfunction)</td></tr><tr><td style=\"white-space:nowrap\">34<a name=\"cs-riskcondition-eu-pcsp-34\"> </a></td><td>Liver problems</td><td>Liver problems</td></tr><tr><td style=\"white-space:nowrap\">35<a name=\"cs-riskcondition-eu-pcsp-35\"> </a></td><td>Iron overload</td><td>Iron overload</td></tr><tr><td style=\"white-space:nowrap\">36<a name=\"cs-riskcondition-eu-pcsp-36\"> </a></td><td>Spleen problems</td><td>Spleen problems</td></tr><tr><td style=\"white-space:nowrap\">37<a name=\"cs-riskcondition-eu-pcsp-37\"> </a></td><td>Tumor predisposition</td><td>Tumor predisposition</td></tr><tr><td style=\"white-space:nowrap\">38<a name=\"cs-riskcondition-eu-pcsp-38\"> </a></td><td>Subsequent melanoma and non-melanoma skin cancer</td><td>Subsequent melanoma and non-melanoma skin cancer</td></tr><tr><td style=\"white-space:nowrap\">39<a name=\"cs-riskcondition-eu-pcsp-39\"> </a></td><td>Subsequent colorectal cancer</td><td>Subsequent colorectal cancer</td></tr><tr><td style=\"white-space:nowrap\">40<a name=\"cs-riskcondition-eu-pcsp-40\"> </a></td><td>Subsequent Oral Cancer</td><td>Subsequent Oral Cancer</td></tr><tr><td style=\"white-space:nowrap\">41<a name=\"cs-riskcondition-eu-pcsp-41\"> </a></td><td>Subsequent acute myeloid leukaemia or myelodysplasia</td><td>Subsequent acute myeloid leukaemia or myelodysplasia</td></tr><tr><td style=\"white-space:nowrap\">42<a name=\"cs-riskcondition-eu-pcsp-42\"> </a></td><td>Subsequent bladder cancer</td><td>Subsequent bladder cancer</td></tr><tr><td style=\"white-space:nowrap\">43<a name=\"cs-riskcondition-eu-pcsp-43\"> </a></td><td>Subsequent Bone Cancer</td><td>Subsequent Bone Cancer</td></tr><tr><td style=\"white-space:nowrap\">44<a name=\"cs-riskcondition-eu-pcsp-44\"> </a></td><td>Subsequent lung cancer</td><td>Subsequent lung cancer</td></tr><tr><td style=\"white-space:nowrap\">45<a name=\"cs-riskcondition-eu-pcsp-45\"> </a></td><td>Subsequent CNS neoplasms</td><td>Subsequent CNS neoplasms</td></tr><tr><td style=\"white-space:nowrap\">46<a name=\"cs-riskcondition-eu-pcsp-46\"> </a></td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td></tr><tr><td style=\"white-space:nowrap\">47<a name=\"cs-riskcondition-eu-pcsp-47\"> </a></td><td>Renal problems (Tubular dysfunction)</td><td>Renal problems (Tubular dysfunction)</td></tr></table></div>"^^rdf:XMLLiteral ]
      ] ; #
      fhir:url [
    fhir:v "http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp"^^xsd:anyURI ;
    fhir:l <http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp>
      ] ; #
      fhir:version [ fhir:v "1.0.0"] ; #
      fhir:name [ fhir:v "CsRiskConditionPcsp"] ; #
      fhir:title [ fhir:v "PCSP Conditions at risk"] ; #
      fhir:status [ fhir:v "active"] ; #
      fhir:experimental [ fhir:v false] ; #
      fhir:date [ fhir:v "2026-01-16T12:01:48+00:00"^^xsd:dateTime] ; #
      fhir:publisher [ fhir:v "PanCareSurPass Project"] ; #
      fhir:contact ( [
    fhir:name [ fhir:v "PanCareSurPass Project" ] ;
        ( fhir:telecom [
    fhir:system [ fhir:v "url" ] ;
    fhir:value [ fhir:v "https://www.pancaresurpass.eu/" ]     ] )
      ] [
    fhir:name [ fhir:v "PanCareSurPass Project" ] ;
        ( fhir:telecom [
    fhir:system [ fhir:v "url" ] ;
    fhir:value [ fhir:v "https://www.pancaresurpass.eu/" ]     ] )
      ] ) ; #
      fhir:description [ fhir:v "Condition at risk proposed by the PCSP algorithm"] ; #
      fhir:jurisdiction ( [
        ( fhir:coding [
    fhir:system [
    fhir:v "http://unstats.un.org/unsd/methods/m49/m49.htm"^^xsd:anyURI ;
    fhir:l <http://unstats.un.org/unsd/methods/m49/m49.htm>       ] ;
    fhir:code [ fhir:v "150" ] ;
    fhir:display [ fhir:v "Europe" ]     ] )
      ] ) ; #
      fhir:caseSensitive [ fhir:v true] ; #
      fhir:content [ fhir:v "complete"] ; #
      fhir:count [ fhir:v "47"^^xsd:nonNegativeInteger] ; #
      fhir:concept ( [
    fhir:code [ fhir:v "1" ] ;
    fhir:display [ fhir:v "Subsequent thyroid cancer" ] ;
    fhir:definition [ fhir:v "Subsequent thyroid cancer" ]
      ] [
    fhir:code [ fhir:v "2" ] ;
    fhir:display [ fhir:v "Subsequent breast cancer" ] ;
    fhir:definition [ fhir:v "Subsequent breast cancer" ]
      ] [
    fhir:code [ fhir:v "3" ] ;
    fhir:display [ fhir:v "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)" ] ;
    fhir:definition [ fhir:v "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)" ]
      ] [
    fhir:code [ fhir:v "4" ] ;
    fhir:display [ fhir:v "Impaired fertility Impaired spermatogenesis" ] ;
    fhir:definition [ fhir:v "Impaired fertility Impaired spermatogenesis" ]
      ] [
    fhir:code [ fhir:v "5" ] ;
    fhir:display [ fhir:v "Testosterone deficiency" ] ;
    fhir:definition [ fhir:v "Testosterone deficiency" ]
      ] [
    fhir:code [ fhir:v "6" ] ;
    fhir:display [ fhir:v "Physical sexual dysfunction" ] ;
    fhir:definition [ fhir:v "Physical sexual dysfunction" ]
      ] [
    fhir:code [ fhir:v "7" ] ;
    fhir:display [ fhir:v "Premature ovarian insufficiency" ] ;
    fhir:definition [ fhir:v "Premature ovarian insufficiency" ]
      ] [
    fhir:code [ fhir:v "8" ] ;
    fhir:display [ fhir:v "Ear problems" ] ;
    fhir:definition [ fhir:v "Ear problems" ]
      ] [
    fhir:code [ fhir:v "9" ] ;
    fhir:display [ fhir:v "Impaired glucose metabolism and diabetes melitus" ] ;
    fhir:definition [ fhir:v "Impaired glucose metabolism and diabetes melitus" ]
      ] [
    fhir:code [ fhir:v "10" ] ;
    fhir:display [ fhir:v "Dyslipidemia" ] ;
    fhir:definition [ fhir:v "Dyslipidemia" ]
      ] [
    fhir:code [ fhir:v "11" ] ;
    fhir:display [ fhir:v "Overweight and obesity" ] ;
    fhir:definition [ fhir:v "Overweight and obesity" ]
      ] [
    fhir:code [ fhir:v "12" ] ;
    fhir:display [ fhir:v "Hypertension" ] ;
    fhir:definition [ fhir:v "Hypertension" ]
      ] [
    fhir:code [ fhir:v "13" ] ;
    fhir:display [ fhir:v "Reduced bone mineral density" ] ;
    fhir:definition [ fhir:v "Reduced bone mineral density" ]
      ] [
    fhir:code [ fhir:v "14" ] ;
    fhir:display [ fhir:v "Osteonecrosis" ] ;
    fhir:definition [ fhir:v "Osteonecrosis" ]
      ] [
    fhir:code [ fhir:v "15" ] ;
    fhir:display [ fhir:v "Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)" ] ;
    fhir:definition [ fhir:v "Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)" ]
      ] [
    fhir:code [ fhir:v "16" ] ;
    fhir:display [ fhir:v "Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)" ] ;
    fhir:definition [ fhir:v "Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)" ]
      ] [
    fhir:code [ fhir:v "17" ] ;
    fhir:display [ fhir:v "Central precocious puberty (CPP) For girls with age below 8 years" ] ;
    fhir:definition [ fhir:v "Central precocious puberty (CPP) For girls with age below 8 years" ]
      ] [
    fhir:code [ fhir:v "18" ] ;
    fhir:display [ fhir:v "Central precocious puberty (CPP) For boys with age below 9 yearss" ] ;
    fhir:definition [ fhir:v "Central precocious puberty (CPP) For boys with age below 9 yearss" ]
      ] [
    fhir:code [ fhir:v "19" ] ;
    fhir:display [ fhir:v "Thyroid function problems" ] ;
    fhir:definition [ fhir:v "Thyroid function problems" ]
      ] [
    fhir:code [ fhir:v "20" ] ;
    fhir:display [ fhir:v "Cerebrovascular problem" ] ;
    fhir:definition [ fhir:v "Cerebrovascular problem" ]
      ] [
    fhir:code [ fhir:v "21" ] ;
    fhir:display [ fhir:v "Neurocognitive problems" ] ;
    fhir:definition [ fhir:v "Neurocognitive problems" ]
      ] [
    fhir:code [ fhir:v "22" ] ;
    fhir:display [ fhir:v "Peripheral neuropathy" ] ;
    fhir:definition [ fhir:v "Peripheral neuropathy" ]
      ] [
    fhir:code [ fhir:v "23" ] ;
    fhir:display [ fhir:v "Cataract" ] ;
    fhir:definition [ fhir:v "Cataract" ]
      ] [
    fhir:code [ fhir:v "24" ] ;
    fhir:display [ fhir:v "Eye problems" ] ;
    fhir:definition [ fhir:v "Eye problems" ]
      ] [
    fhir:code [ fhir:v "25" ] ;
    fhir:display [ fhir:v "Craniofacial growth problems" ] ;
    fhir:definition [ fhir:v "Craniofacial growth problems" ]
      ] [
    fhir:code [ fhir:v "26" ] ;
    fhir:display [ fhir:v "Spine scoliosis and kyphosis" ] ;
    fhir:definition [ fhir:v "Spine scoliosis and kyphosis" ]
      ] [
    fhir:code [ fhir:v "27" ] ;
    fhir:display [ fhir:v "Lower urinary tract problems" ] ;
    fhir:definition [ fhir:v "Lower urinary tract problems" ]
      ] [
    fhir:code [ fhir:v "28" ] ;
    fhir:display [ fhir:v "Obstetric problems" ] ;
    fhir:definition [ fhir:v "Obstetric problems" ]
      ] [
    fhir:code [ fhir:v "29" ] ;
    fhir:display [ fhir:v "Dental and oral problems" ] ;
    fhir:definition [ fhir:v "Dental and oral problems" ]
      ] [
    fhir:code [ fhir:v "30" ] ;
    fhir:display [ fhir:v "Gastro-intestinal problems" ] ;
    fhir:definition [ fhir:v "Gastro-intestinal problems" ]
      ] [
    fhir:code [ fhir:v "31" ] ;
    fhir:display [ fhir:v "Arrhythmia" ] ;
    fhir:definition [ fhir:v "Arrhythmia" ]
      ] [
    fhir:code [ fhir:v "32" ] ;
    fhir:display [ fhir:v "Pulmonary problems" ] ;
    fhir:definition [ fhir:v "Pulmonary problems" ]
      ] [
    fhir:code [ fhir:v "33" ] ;
    fhir:display [ fhir:v "Renal problems (Glomerular dysfunction - Tubular dysfunction)" ] ;
    fhir:definition [ fhir:v "Renal problems (Glomerular dysfunction - Tubular dysfunction)" ]
      ] [
    fhir:code [ fhir:v "34" ] ;
    fhir:display [ fhir:v "Liver problems" ] ;
    fhir:definition [ fhir:v "Liver problems" ]
      ] [
    fhir:code [ fhir:v "35" ] ;
    fhir:display [ fhir:v "Iron overload" ] ;
    fhir:definition [ fhir:v "Iron overload" ]
      ] [
    fhir:code [ fhir:v "36" ] ;
    fhir:display [ fhir:v "Spleen problems" ] ;
    fhir:definition [ fhir:v "Spleen problems" ]
      ] [
    fhir:code [ fhir:v "37" ] ;
    fhir:display [ fhir:v "Tumor predisposition" ] ;
    fhir:definition [ fhir:v "Tumor predisposition" ]
      ] [
    fhir:code [ fhir:v "38" ] ;
    fhir:display [ fhir:v "Subsequent melanoma and non-melanoma skin cancer" ] ;
    fhir:definition [ fhir:v "Subsequent melanoma and non-melanoma skin cancer" ]
      ] [
    fhir:code [ fhir:v "39" ] ;
    fhir:display [ fhir:v "Subsequent colorectal cancer" ] ;
    fhir:definition [ fhir:v "Subsequent colorectal cancer" ]
      ] [
    fhir:code [ fhir:v "40" ] ;
    fhir:display [ fhir:v "Subsequent Oral Cancer" ] ;
    fhir:definition [ fhir:v "Subsequent Oral Cancer" ]
      ] [
    fhir:code [ fhir:v "41" ] ;
    fhir:display [ fhir:v "Subsequent acute myeloid leukaemia or myelodysplasia" ] ;
    fhir:definition [ fhir:v "Subsequent acute myeloid leukaemia or myelodysplasia" ]
      ] [
    fhir:code [ fhir:v "42" ] ;
    fhir:display [ fhir:v "Subsequent bladder cancer" ] ;
    fhir:definition [ fhir:v "Subsequent bladder cancer" ]
      ] [
    fhir:code [ fhir:v "43" ] ;
    fhir:display [ fhir:v "Subsequent Bone Cancer" ] ;
    fhir:definition [ fhir:v "Subsequent Bone Cancer" ]
      ] [
    fhir:code [ fhir:v "44" ] ;
    fhir:display [ fhir:v "Subsequent lung cancer" ] ;
    fhir:definition [ fhir:v "Subsequent lung cancer" ]
      ] [
    fhir:code [ fhir:v "45" ] ;
    fhir:display [ fhir:v "Subsequent CNS neoplasms" ] ;
    fhir:definition [ fhir:v "Subsequent CNS neoplasms" ]
      ] [
    fhir:code [ fhir:v "46" ] ;
    fhir:display [ fhir:v "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)" ] ;
    fhir:definition [ fhir:v "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)" ]
      ] [
    fhir:code [ fhir:v "47" ] ;
    fhir:display [ fhir:v "Renal problems (Tubular dysfunction)" ] ;
    fhir:definition [ fhir:v "Renal problems (Tubular dysfunction)" ]
      ] ) . #